Cardiac Effects of COVID-19 Infection, MIS-C, and the Vaccine in Infants and Children: What Is Known and Future Implications
Document Type
Journal Article
Publication Date
12-1-2022
Journal
American journal of perinatology
Volume
39
Issue
S 01
DOI
10.1055/s-0042-1757238
Abstract
The cardiac effects of novel coronavirus disease 2019 (COVID-19) infection on the pediatric heart has become an area of particular interest as elevated cardiac enzymes and abnormalities on echocardiogram and electrocardiogram were seen in a portion of children affected by the virus. In this article, we review the cardiac manifestations of acute COVID-19 infection, multisystem inflammatory syndrome in children, and postvaccine myocarditis. The limited research on the effects of COVID-19 on neonates and infants is also reported. KEY POINTS: · Cardiac involvement from MIS-C is much higher than the risk of COVID-19 vaccine-induced myocarditis.. · Neonates and infants have overall been less affected by COVID-19 than adults and older children.. · At this point in time, there is limited research on the cardiac effects of COVID-19 in neonates..
APA Citation
Schwartz, Bryanna N.; Harahsheh, Ashraf S.; Krishnan, Anita; and Martin, Gerard R., "Cardiac Effects of COVID-19 Infection, MIS-C, and the Vaccine in Infants and Children: What Is Known and Future Implications" (2022). GW Authored Works. Paper 2188.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/2188
Department
Pediatrics
